VCAM1 and Sepsis: Consistent with the increased H3K14la levels, expression levels of both VCAM‐1 and TF, two biomarkers of EC activation, were decreased by 2DG and oxamate pretreatment, indicating the alleviation of sepsis‐induced pulmonary EC activation (Figure 3K–N; Figure S2G–J).